We are excited to announce that Fred Ghanem has joined Sunresin as Vice President of Life Science division managing the American market. Fred has 25 years experience in Ion Exchange Resins, adsorbents and specialty resins and 4 years in catalysis. With a Master of Science in Chemical Engineering and Biotechnology and a PhD in Chemical Engineering, expected 2023, Fred is a great asset that will help the company to grow substantially in the Life Science market.
We are excited to announce that Sunresin New Material has entered in a collaboration agreement starting from August 2023 with Prof Fernando Albericio and Prof Beatriz G. De La Torre from University of KwaZulu-Natal (UKZN), South Africa, for the development of new resins for Solid-Phase Peptide Synthesis (SPPS), optimization of existing products and the development of novel chemistry to support pharmaceutical industry. Fernando does not need presentation. With more than 1000 publications in the field of SPPS and many patents, Fernando has helped for decades the peptide market to grow, expand and support patient life with the discovery of efficient processes for the manufacture of peptide APIs. Sunresin is now a recognized global leading company manufacturing on multiple ton scale resins that allow the production of API peptide by solid phase synthesis.
Sunresin is a leading company manufacturing Ion exchange resins, adsorbents and specialty resins for different industries. Sunresin has its headquarter in Xi’an China and is rapidly expanding globally. For our international Life Science division we looking for a Regulatory and QA manager able to assist the company growing in this field.